World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
81
Citations
38464
World Ranking
1078
National Ranking
488

Emilio A. Emini publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Emilio A. Emini sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 249 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Emilio A. Emini D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Emilio A. Emini sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 81 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Emilio A. Emini is affiliated with Pfizer in the United States. Their research primarily focuses on medicine, with specific interests in infectious diseases, genetics, and hepatology. The scientist's work spans multiple topics including HIV/AIDS drug development and treatment, chronic lymphocytic leukemia research, and hepatitis C virus research.

Among the recent publications, there is a paper titled "Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy," published in 2020 in UNC Libraries. This publication recorded citations in the academic community reflecting engagement with the work.

Frequent collaborators include John W. Mellors, Leslie Jonas, Fred Valentine, Roy M. Gulick, and Diane V. Havlir. These coauthors have appeared alongside Emilio A. Emini in published research, contributing to studies in their shared fields of interest.

Publication venues for Emilio A. Emini's research are noted to include UNC Libraries, showcasing contributions to that platform.

Main topics of their research work are as follows:

  • HIV/AIDS drug development and treatment
  • Chronic Lymphocytic Leukemia Research
  • Hepatitis C virus research

Coauthors frequently involved in Emilio A. Emini's works include:

  • John W. Mellors
  • Leslie Jonas
  • Fred Valentine
  • Roy M. Gulick
  • Diane V. Havlir

Main fields of study pursued are:

  • Medicine

Subfields of study where Emilio A. Emini has contributed include:

  • Infectious Diseases
  • Genetics
  • Hepatology

This profile summarizes the academic research footprint of Emilio A. Emini, reflecting their involvement in medical sciences and infectious disease research through collaborative publications and topical expertise.

Best Publications

  • Viral dynamics in human immunodeficiency virus type 1 infection

    Xiping Wei;Sajal K. Ghosh;Maria E. Taylor;Victoria A. Johnson

  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

    R M Gulick;J W Mellors;D Havlir;J J Eron

  • Active human immunodeficiency virus protease is required for viral infectivity.

    Nancy E. Kohl;Emilio A. Emini;William A. Schleif;Lenora J. Davis

  • Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

    E A Emini;J V Hughes;D S Perlow;J Boger

  • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  • Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

    Marc J.M. Bonten;Susanne M. Huijts;Marieke Bolkenbaas;Chris Webber

  • Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

    Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda

  • Primary structure, gene organization and polypeptide expression of poliovirus RNA

    Naomi Kitamura;Bert L. Semler;Paul G. Rothberg;Glenn R. Larsen

  • In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

    Unknown

  • L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase.

    S D Young;S F Britcher;L O Tran;L S Payne

  • Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

    E. A. Emini;W. A. Schleif;J. H. Nunberg;J. H. Nunberg;A. J. Conley

  • Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene

    Danilo R. Casimiro;Ling Chen;Tong-Ming Fu;Robert K. Evans

  • L-735,524 : the design of a potent and orally bioavailable HIV protease inhibitor

    B D Dorsey;R B Levin;S L McDaniel;J P Vacca

  • Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.

    J H Nunberg;W A Schleif;E J Boots;J A O'Brien

  • Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

    Jiang Fan;Xiaoping Liang;Melanie S Horton;Helen C Perry

  • A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

    Daria J. Hazuda;Neville J. Anthony;Robert P. Gomez;Samson M. Jolly

  • Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.

    John W Shiver;Emilio A Emini

  • Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.

    M K Gorny;A J Conley;S Karwowska;A Buchbinder

  • Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

    Daria J. Hazuda;Steven D. Young;James P. Guare;Neville J. Anthony

  • Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

    Andrés de Roux;B. Schmöele-Thoma;G. R. Siber;J. G. Hackell

  • Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

    Danilo R. Casimiro;Fubao Wang;William A. Schleif;Xiaoping Liang

  • 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

    T M Williams;T M Ciccarone;S C MacTough;C S Rooney

  • Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure

    Joseph K. Wong;Huldrych F. Günthard;Diane V. Havlir;Zhi Qiang Zhang

Frequent Co-Authors

John W. Shiver
John W. Shiver United States Military Academy
Danilo R. Casimiro
Danilo R. Casimiro United States Military Academy
William C. Gruber
William C. Gruber Pfizer (United States)
Daniel A. Scott
Daniel A. Scott Pfizer (United States)
Eckard Wimmer
Eckard Wimmer Stony Brook University
Tong-Ming Fu
Tong-Ming Fu The University of Texas Health Science Center
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Diane V. Havlir
Diane V. Havlir University of California, San Francisco
Joseph P. Vacca
Joseph P. Vacca MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various career pathways beyond traditional lab roles. Many professionals explore related fields that combine biology and healthcare, offering diverse options for growth and specialization. For those with unique challenges, there are accessible educational opportunities such as online degrees for felons, which provide a vital second chance for pursuing science-related careers.

Healthcare roles like a Functional Medicine Nurse Practitioner offer promising career prospects. With a focus on holistic and integrative approaches, the functional medicine nurse practitioner salary reflects the growing demand for professionals skilled in this area, making it a lucrative pathway for microbiology graduates interested in patient care.

Another viable option involves health administration, where skills in coding and data management are critical. Becoming a Certified Professional Coder (CPC) links medical knowledge with precise documentation and billing processes. Understanding the cpc salary offers insights into the financial benefits of this career.

Similarly, careers in health information management allow microbiology graduates to manage healthcare data systems effectively. Entry-level roles show promising growth, highlighted by the health information management salary entry-level, making it an attractive option for those interested in the intersection of healthcare and technology.

Best Scientists Citing Emilio A. Emini

Trending Scientists